Utah life sciences companies, and BioUtah members, ProLung, Inc., and Rosivo Inc., were among ten innovative companies announced as winners in the 16th annual Utah Innovation Awards, presented by Stoel Rives, LLP, and the Utah Technology Council. Winners were honored during a special awards dinner, April 26, at the Hilton Salt Lake City Center.
The Utah Innovations Awards program recognizes groundbreaking accomplishments in a variety of categories, including Early Stage Innovation, Medical Device and Biotechnology. BioUtah was a program sponsor.
ProLung won in the biotechnology category for its rapid, non-invasive ProLung Test™ to assess the risk of malignancy in lung nodules found in the chest. Rosivo won in the medical device category for Cartesse™, a patent pending and first of its kind off-the-shelf cartilage implant that will transform the standard of care in nose and ear repairs. Tolero Pharmaceuticals was an award finalist in the Early State Innovation category. Other finalists acknowledged in the life sciences field included OpenSight and PhotoPharmics.
"BioUtah couldn't be more proud of our winners and finalists," said Richard Ji, Chairman of the BioUtah Board of Directors, who attended the event. "These award recipients epitomize the innovation and entrepreneurship that makes Utah a true hub for the life sciences."
First place award winners ProLung and Rosivo, and the other life sciences finalists all chose to start and grow their companies in Utah. "The fact that these companies are putting down roots in Utah is a testament to the talent and culture of innovation and collaboration we have in the state," noted Kelly Slone, President and CEO of BioUtah, who also attended the event. "The cutting-edge advances they're producing are absolutely life-changing for patients."